NCT03873415View on ClinicalTrials.gov

Assessment of Gut Absorption of Experimental Medication BMS-986165 in Healthy Males

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 25, 2019

Primary Completion Date

May 1, 2019

Study Completion Date

May 1, 2019

Conditions
Psoriasis
Interventions
DRUG

BMS-986165

Oral administration

Trial Locations (1)

40504

Scintipharma, Lexington

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY